Among Spanish adults with biopsy-proven glomerular disease (n = 493), SGLT2 inhibition resulted in a mean 48% proteinuria reduction at 1 year follow up, occurring less often in those with serum albumin < 3.5 g/L. This evidence concerns the gene SLC5A2 and glomerular disorder.